- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01224600
EValuation of Systemic Atherothrombosis in Patients With ARTerial Disease of the Lower Limbs (EVART)
March 5, 2015 updated by: Institut de l'Atherothrombose
The purpose of this study is to determine the prevalence and risk factors, at the time of the diagnosis of PAD, for asymptomatic carotid stenosis and abdominal aortic aneurysm.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
The EVART study is a prospective epidemiological multicenter cohort study, including patients with newly diagnosed PAD (< 1 year).
Initial data on medical history, caracterisation of the PAD (risk factors, main sites and severity of the atherosclerotic lesions),clinical evaluation of undetected previous CV events, standardized US duplex examination of the abdominal aorta and carotid arteries and treatment (type and duration) are collected by the physician into an electronic medical record.
A phone follow up at 3 months, 1, 2 and 3 years is realised by the Centre for Clinical Research of Grenoble.
Data on mortality, revascularization, treatments prescribed (type and duration), cancer onset, cardiovascular events, carotid stenosis, abdominal aortic aneurysm are collected.
All these serious adverse events are documented and reviewed by an independent critical events committee.
Study Type
Observational
Enrollment (Actual)
1056
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Chênée, Belgium, 04032
- University Hospital Liege
-
-
-
-
-
Abbeville, France, 80100
- Hospital
-
Alençon, France, 61000
- Office-based Specialist in vascular medecine
-
Ambarès et Lagrave, France, 33440
- Office-based Specialist in vascular medecine
-
Amiens, France, 80054
- University Hospital Amiens
-
Amiens, France, 80094
- Office-based Specialist in vascular medecine
-
Annecy, France, 74000
- Office-based Specialist in vascular medecine
-
Armentières, France, 59280
- Hospital center Armentières
-
Arpajon, France, 91290
- Office-based Specialist in vascular medecine
-
Auxerre, France, 89000
- Office-based Specialist in vascular medecine
-
Basse-terre (Guadeloupe), France, 97100
- Office-based Specialist in vascular medecine
-
Beauvais, France, 60000
- Office-based Specialist in vascular medecine
-
Blagnac, France, 31700
- Office-based Specialist in vascular medecine
-
Bordeaux, France, 33075
- Hospital Saint-André
-
Bordeaux, France, 33300
- Office-based Specialist in vascular medecine
-
Boulogne Sur Mer, France, 62321
- Hospital center
-
Bourg-en-Bresse, France, 01000
- Office-based Specialist in vascular medecine
-
Bourgoin-Jallieu, France, 38300
- Office-based Specialist in vascular medecine
-
Brest, France, 29609
- University Hospital Brest
-
Brest, France, 29200
- Office-based Specialist in vascular medecine
-
Bretigny, France, 91220
- Office-based Specialist in vascular medecine
-
Brive La Gaillarde, France, 19312
- Hospital center
-
Caen, France, 14033
- University Hospital Caen
-
Cannes, France, 06400
- Office-based Specialist in vascular medecine
-
Carcassonne, France, 11000
- Office-based Specialist in vascular medecine
-
Carcassonne, France, 11890
- Hospital Antoine Gayraud
-
Castres, France, 81100
- Office-based Specialist in vascular medecine
-
Ceyrat, France, 63122
- Office-based Specialist in vascular medecine
-
Chalon-sur-Saone, France, 71100
- Office-based Specialist in vascular medecine
-
Chambéry, France, 73000
- Office-based Specialist in vascular medecine
-
Chartres, France, 28000
- Office-based Specialist in vascular medecine
-
Chesnay, France, 78150
- Hospital Center Versailles
-
Cholet, France, 49300
- Office-based Specialist in vascular medecine
-
Clermont-Ferrand, France, 63000
- Office-based Specialist in vascular medecine
-
Cluses, France, 74300
- Office-based Specialist in vascular medecine
-
Cognac, France, 16100
- Office-based Specialist in vascular medecine
-
Compiègne, France, 60321
- Hospital Center Compiègne
-
Crolles, France, 38920
- Office-based Specialist in vascular medecine
-
Denain, France, 59220
- Office-based Specialist in vascular medecine
-
Dijon, France, 21079
- Bocage Hospital
-
EU, France, 76260
- Office-based Specialist in vascular medecine
-
Ermont, France, 95120
- Office-based Specialist in vascular medecine
-
Fecamp, France, 76400
- Office-based Specialist in vascular medecine
-
Foix, France, 09000
- Hospital center Val d'Ariège
-
Fort de France, France, 97200
- Office-based Specialist in vascular medecine
-
Grenoble, France, 38043
- University Hospital Grenoble
-
Grenoble, France, 38000
- Office-based Specialist in vascular medecine
-
Issy les Moulineaux, France, 92130
- Office-based Specialist in vascular medecine
-
La Membrolle, France, 49770
- Office-based Specialist in vascular medecine
-
La Rochelle, France, 17000
- Office-based Specialist in vascular medecine
-
Lens, France, 62307
- Hospital Center Lens
-
Levallois-Perret, France, 92300
- Office-based Specialist in vascular medecine
-
Lille, France, 59037
- University Hospital Lille
-
Limoges, France, 87042
- University Hospital Limoges
-
Limoges, France, 87100
- Office-based Specialist in vascular medecine
-
Lomme, France, 59462
- Hospital Saint Philibert
-
Lomme, France, 59160
- Office-based Specialist in vascular medecine
-
Longwy, France, 54440
- Office-based Specialist in vascular medecine
-
Lyon, France, 69003
- Edouard Herriot Hospital
-
Lyon, France, 69007
- Office-based Specialist in vascular medecine
-
Malemort-sur-Correze, France, 19360
- Office-based Specialist in vascular medecine
-
Maubeuge, France, 59600
- Office-based Specialist in vascular medecine
-
Montbéliard, France, 25200
- Hospital of Belfort
-
Montelimar, France, 26200
- Office-based Specialist in vascular medecine
-
Montluçon, France, 03100
- Office-based Specialist in vascular medecine
-
Montpellier, France, 34295
- University Hospital Montpellier
-
Mulhouse, France, 68200
- Office-based Specialist in vascular medecine
-
Nice, France, 06000
- Office-based Specialist in vascular medecine
-
Niort, France, 79000
- Office-based Specialist in vascular medecine
-
Noumea, France, 98895
- Office-based Specialist in vascular medecine
-
Orleans, France, 45100
- Office-based Specialist in vascular medecine
-
Orléans, France, 45000
- Hospital center
-
Papeete, France, 98713
- Hospital center Territorial Mamao
-
Paris, France, 75116
- Office-based Specialist in vascular medecine
-
Peronne, France, 80200
- Office-based Specialist in vascular medecine
-
Perpignan, France, 66000
- Office-based Specialist in vascular medecine
-
Pontcharra, France, 38530
- Office-based Specialist in vascular medecine
-
Pornic, France, 44210
- Office-based Specialist in vascular medecine
-
Puilboreau, France, 17138
- Office-based Specialist in vascular medecine
-
Périgueux, France, 24000
- Hospital center
-
Rambouillet, France, 78120
- Office-based Specialist in vascular medecine
-
Rochefort, France, 17300
- Office-based Specialist in vascular medecine
-
Rodez, France, 12000
- Office-based Specialist in vascular medecine
-
Rodez, France, 12027
- Hospital center Rodez
-
Rouen, France, 76100
- Office-based Specialist in vascular medecine
-
Saint Aubin de Medoc, France, 33160
- Office-based Specialist in vascular medecine
-
Saint Aubin sur Scie, France, 76550
- Office-based Specialist in vascular medecine
-
Saint Etienne, France, 42100
- University Hospital Saint Etienne
-
Saint benoît, France, 86280
- Office-based Specialist in vascular medecine
-
Saint-Etienne, France, 42000
- Office-based Specialist in vascular medecine
-
Saint-Lo, France, 50000
- Memorial Hospital
-
Saint-Lo, France, 50000
- Office-based Specialist in vascular medecine
-
Saint-Priest, France, 69800
- Office-based Specialist in vascular medecine
-
Saint-Quentin, France, 02100
- Hospital
-
Sallanches, France, 74700
- Office-based Specialist in vascular medecine
-
Sarcelles, France, 95200
- Office-based Specialist in vascular medecine
-
Sarrebourg, France, 57400
- Office-based Specialist in vascular medecine
-
Sarreguemines, France, 57200
- Office-based Specialist in vascular medecine
-
Savigny-sur-Orge, France, 91600
- Office-based Specialist in vascular medecine
-
Selestat, France, 67600
- Office-based Specialist in vascular medecine
-
Strasbourg, France, 67000
- Office-based Specialist in vascular medecine
-
Toulon, France, 83000
- Office-based Specialist in vascular medecine
-
Toulouse, France, 31059
- University Hospital Rangueil
-
Toulouse, France, 31076
- Office-based Specialist in vascular medecine
-
Tours, France, 37000
- Office-based Specialist in vascular medecine
-
Trelaze, France, 49800
- Office-based Specialist in vascular medecine
-
Trois-Rivières (Guadeloupe), France, 97114
- Office-based Specialist in vascular medecine
-
Vannes, France, 56000
- Office-based Specialist in vascular medecine
-
Versailles, France, 78000
- Office-based Specialist in vascular medecine
-
Vienne, France, 38200
- Office-based Specialist in vascular medecine
-
Villeurbanne, France, 69100
- Office-based Specialist in vascular medecine
-
Vincennes, France, 94300
- Office-based Specialist in vascular medecine
-
Vizille, France, 38220
- Office-based Specialist in vascular medecine
-
Voiron, France, 38500
- Office-based Specialist in vascular medecine
-
Wissembourg, France, 67160
- Office-based Specialist in vascular medecine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients with newly diagnosed PAD < 1 year symptomatic or asymptomatic without any hystory of previous coronary nor cerebrovascular event
Description
Inclusion Criteria:
- patient with newly diagnosed PAD < 1 year
- symptomatic or asymptomatic : ABI<0.9 at rest, claudicants with ABI<0.85 after treadmill test, or symptomatic patients (Edimburgh questionnaire or trophic changes) with ABI>1.30
Exclusion Criteria:
- history of previous coronory or cerebrovascular event
- previous investigation of the aorta and cervical arteries
- prisoners
- subjets with no affiliation to the social security system or equivalent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
1
patient with newly diagnosed PAD (< 1 year)
|
patients with newly diagnosed PAD (<1year) symptomatic or asymptomatic, without any history of previous coronary nor cerebrovascular event, and with no previous investigation of the aorta and cervical arteries were eligible
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
prevalence and risk factors, at the time of the diagnosis PAD, for asymptomatic carotid stenosis and abdominal aortic aneurysm
Time Frame: evaluation during inclusion visit
|
evaluation during inclusion visit
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
clinical forms of aortic aneurysm and carotid stenosis, clinical stage of PAD, ABI level, proximal predominance, age, gender, cardiovascular risk factors will be tested like potential aneurysm or carotid stenosis risk factor
Time Frame: evaluation during inclusion visit
|
evaluation during inclusion visit
|
|
frequency of prescription of cardiac consultation,coronarography, stress ECG, stress echo, thallium scan and renal and digestive doppler ultrasound. Frequency of coronary and renal revascularization
Time Frame: evaluation during inclusion visit
|
evaluation during inclusion visit
|
|
frequency of drug prescription (beta blocker, statin,antiplatelet,ICE, other hypolipidaemic...) Non-drug prescription : dietetic, tabagism, rehabilitation for walking and structured therapeutic education, dietary management
Time Frame: evaluation during inclusion visit
|
evaluation during inclusion visit
|
|
incidence and cardiovascular risk factor
Time Frame: 3 months, 1, 2 and 3 years
|
3 months, 1, 2 and 3 years
|
|
incidence of thromboembolic disease (symptomatic DVT and/or PE) proved by additional examinations
Time Frame: 3 Months, 1, 2 and 3 years
|
3 Months, 1, 2 and 3 years
|
|
useful of the screening
Time Frame: 3 years
|
decision analysis
|
3 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Patrick CARPENTIER, Professor, University Hospital, Grenoble
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2008
Primary Completion (ACTUAL)
March 1, 2011
Study Completion (ACTUAL)
March 1, 2014
Study Registration Dates
First Submitted
September 15, 2010
First Submitted That Met QC Criteria
October 19, 2010
First Posted (ESTIMATE)
October 20, 2010
Study Record Updates
Last Update Posted (ESTIMATE)
March 6, 2015
Last Update Submitted That Met QC Criteria
March 5, 2015
Last Verified
March 1, 2015
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Cardiovascular Diseases
- Vascular Diseases
- Cerebrovascular Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Arteriosclerosis
- Arterial Occlusive Diseases
- Atherosclerosis
- Carotid Artery Diseases
- Aortic Diseases
- Peripheral Arterial Disease
- Peripheral Vascular Diseases
- Carotid Stenosis
- Aneurysm
- Aortic Aneurysm
- Aortic Aneurysm, Abdominal
Other Study ID Numbers
- DCIC 0704
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Peripheral Arterial Disease
-
University of NebraskaNot yet recruitingPeripheral Arterial Disease | Peripheral Vascular Diseases | Peripheral Arterial Occlusive Disease | Peripheral Artery DiseaseUnited States
-
CID S.p.A.Meditrial Europe Ltd.Not yet recruitingPeripheral Arterial Occlusive Disease | Peripheral Artery DiseaseItaly
-
Marissa JarosinskiRecruitingPeripheral Arterial Occlusive Disease | Peripheral Vascular Disease | Peripheral Artery Disease | Clopidogrel, Poor Metabolism of | Artery DiseaseUnited States
-
Stanford UniversityTerminatedPAD - Peripheral Arterial Disease | PVD- Peripheral Vascular DiseaseUnited States
-
Vascuros Medical Pte LtdNovella ClinicalUnknownPeripheral Arterial Occlusive Disease | Peripheral Vascular Disease | Peripheral Artery DiseaseSingapore, Belgium, Germany
-
Western Vascular Institute, IrelandRecruitingPeripheral Arterial Occlusive DiseaseIreland
-
Jena University HospitalAngioDroid s.r.l., Bologna (Italy)CompletedPeripheral Arterial Occlusive DiseaseGermany
-
Seoul National University HospitalAstellas Pharma Korea, Inc.CompletedPeripheral Arterial Occlusive DiseaseKorea, Republic of
-
Heidelberg UniversityTerminatedPeripheral Arterial Occlusive DiseaseGermany
-
Johann Wolfgang Goethe University HospitalSuspendedPeripheral Arterial Occlusive DiseaseGermany
Clinical Trials on patients with newly diagnosed PAD (<1year)
-
Postgraduate Institute of Dental Sciences RohtakCompletedPolycystic Ovary Syndrome | Gingival InflammationIndia
-
Instituto de Investigación Marqués de ValdecillaRecruitingObstructive Sleep Apnea | Positive Airway PressureSpain
-
University of Alabama at BirminghamCompletedMultiple Sclerosis (MS)United States
-
China National Center for Cardiovascular DiseasesRecruiting
-
Merck Sharp & Dohme LLCCompleted
-
Pediatric Brain Tumor ConsortiumNational Cancer Institute (NCI); Solving Kids' Cancer; Ty Louis Campbell Foundation and other collaboratorsActive, not recruitingGlioblastoma Multiforme | Medulloblastoma | High-grade Astrocytoma NOS | CNS Primary Tumor, Nos | Ependymoma, NOS | Diffuse Intrinsic Pontine Gliomas (DIPG)United States
-
Bursa Yüksek İhtisas Education and Research HospitalCompleted
-
Affiliated Hospital to Academy of Military Medical...CompletedUlcerative Colitis | Dopamine Dysregulation SyndromeChina
-
Gaziosmanpasa Research and Education HospitalRecruiting